Postacute COVID syndrome, an ongoing inflammatory state following infection with SARS-CoV-2, is associated with greater risk of metabolic-associated fatty liver disease.
Retrospective studies have suggested that Roux-en-Y gastric bypass may be more effective in countering hepatic steatosis, but randomized trials have been lacking.
Bariatric surgery significantly reduces the risk of major adverse liver and cardiovascular events in recipients, compared with nonsurgical counterparts, among those with nonalcoholic fatty liver disease.
"This is the closest we re ever going to get to a linkage between what people are eating or drinking and the health of their liver," said the study s senior author.